ClinicalTrials.govpublic full text
BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer
metastatic hepatocellular carcinoma, stage iii hepatocellular carcinoma ajcc v8, stage iiia hepatocellular carcinoma ajcc v8, stage iiib hepatocellular carcinoma ajcc v8, stage iv hepatocellular carcinoma ajcc v8, stage iva hepatocellular carcinoma ajcc v8, stage ivb hepatocellular carcinoma ajcc v8, unresectable hepatocellular carcinoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 917712
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.